Pfizer says patient died in oral rheumatoid drug study !

Posted by stockinvestips on 10:43 PM in , | 0 comments
Pfizer ( NYSE: PFE ) said four patients enrolled in a trial studying its oral rheumatoid arthritis drug tofacitinib died during or after treatment, but that only one death has been linked to the drug, the WSJ reports. Full results of the study are due to be presented May 27 at a scientific meeting in London. Thursday( April 21), the stock of the company plunged  almost 3% to close at $ 19.79.
Tags: ,

About author

Make it happen !!

0 comments

Leave a Reply

Newer Post Older Post Home